Pediatric pulmonologists from Columbia and Weill Cornell Medicine provide specialized testing and novel therapies for respiratory disorders in children of all ages. Through major centers in cystic fibrosis, asthma, sleep disorders, and aerodigestive and neuromuscular disorders, our physicians partner with the patient and their parents to personalize treatment, including participation in clinical trials of the latest therapies, with the goal of helping young patients lead a normal and healthy childhood.
Pediatric Pulmonology
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
